Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Reolysin to enter phase I trial in pediatric patients with solid tumors

Nov. 19, 2010

Astex Therapeutics claims new fibroblast growth factor receptor inhibitors

Nov. 19, 2010

Ipsen Pharma identifies new imidazolidine-2,4-dione derivatives for prostate cancer

Nov. 19, 2010

Morphotek and Hokkaido University join to evaluate amatuximab for pancreatic cancer

Nov. 19, 2010

Aveo Pharma advances phase Ib tivozanib/capecitabine combination trial

Nov. 19, 2010

Exelixis divulges novel mTORC1 inhibitors

Nov. 19, 2010

FDA advisory committee recommends approval of Merck & Co.'s sBLA for Gardasil

Nov. 18, 2010

EMA accepts Pixuvri MAA for non-Hodgkin's lymphoma for review

Nov. 18, 2010

New tyrosine protein kinase inhibitor-oligomer conjugates claimed

Nov. 18, 2010

EMA approves Cell Therapeutics' pediatric investigation plan for Pixuvri

Nov. 17, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...